- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/37 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
Patent holdings for IPC class C12Q 1/37
Total number of patents in this class: 1914
10-year publication summary
150
|
121
|
141
|
125
|
146
|
97
|
113
|
93
|
97
|
7
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19517 |
36 |
Massachusetts Institute of Technology | 9913 |
36 |
Biomadison, Inc. | 48 |
34 |
Expression Pathology, Inc. | 112 |
26 |
The University of Tokyo | 4060 |
24 |
Glympse bio, Inc. | 33 |
19 |
Allergan, Inc. | 2438 |
16 |
Takeda Pharmaceutical Company Limited | 2943 |
16 |
Regeneron Pharmaceuticals, Inc. | 3986 |
15 |
bioMerieux | 928 |
14 |
F. Hoffmann-La Roche AG | 7942 |
13 |
Centre National de La Recherche Scientifique | 10102 |
13 |
The Johns Hopkins University | 5533 |
13 |
Seikagaku Corporation | 190 |
12 |
Mologic Ltd | 41 |
11 |
Sekisui Medical Co., Ltd. | 651 |
11 |
Kansas State University Research Foundation | 436 |
10 |
Orbsen Therapeutics Limited | 34 |
10 |
Promega Corporation | 557 |
10 |
Siemens Healthcare Diagnostics Products GmbH | 150 |
10 |
Other owners | 1565 |